Hippo-TAZ/YAP信号通路在头颈部鳞状细胞癌中的研究进展

摘要/Abstract

摘要： Hippo 信号通路是近年来新发现的一个高度保守的蛋白激酶级联通路。其中，TAZ/YAP是该信号通路中核心的效应分子。大量研究证实，TAZ/YAP与人类大多数恶性肿瘤的发生或生长密切相关，其异常活化可促进肿瘤细胞增殖、侵袭转移、增强化疗耐药及获得干细胞样特性。近年来研究表明，TAZ/YAP异常活化与头颈部肿瘤的发生发展密切相关，其有可能作为头颈部肿瘤治疗的潜在靶点。本文综述Hippo通路的最新研究进展，重点关注的是该通路中的TAZ/YAP在头颈部鳞状细胞癌中的调控作用，为头颈部鳞状细胞癌的研究和治疗提供新的思路和策略。

关键词: Hippo信号通路, TAZ, YAP, 头颈部鳞状细胞癌, 肿瘤

Abstract: Hippo pathway plays as an evolutionarily conserved protein kinase cascade pathway, among which TAZ/YAP is the core effector molecules in this signaling pathway. Many studies have shown that YAP and TAZ are highly related with the occurrence and development of most human malignancies, and its abnormal activation can promote tumor cell proliferation, invasion and metastasis, enhance chemotherapy resistance and obtain stem cell properties. Recent studies indicate that TAZ/YAP are essential for cancer initiation or growth of most human cancers. Recent research findings show that the Hippo-TAZ/YAP signaling pathway is closely associated with the development and progression of HNSCC and inhibition of the activity of this pathway may become a new method for the treatment of HNSCC. This article reviews the latest progress of the Hippo pathway, focuses on the regulation of Hippo-TAZ/YAP signaling pathway in HNSCC, and provides new ideas and strategies for HNSCC research and treatment.

Key words: Hippo signaling pathway, TAZ, YAP, HNSCC, Carcinoma

中图分类号:

　R739.8

邵伟华李晋龚炜韬俞张红韩兴怡章馨钰杨建荣李中武. Hippo-TAZ/YAP信号通路在头颈部鳞状细胞癌中的研究进展[J]. 口腔医学, 2020, 40(1): 71-77.

参考文献 73

[1]	Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide: sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136(5):E359-E386
[2]	Xu T, Wang W, Zhang S, et al.Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase[J].Development, 1995, 121(4):1053-1063
[3]	Halder G, Johnson R L.Hippo signaling: growth control and beyond[J].Development, 2011, 138(1):9-22
[4]	Yin M, Zhang L.Hippo signaling: a hub of growth control,tumor suppression and pluripotency maintenance[J].J Genet Genomics, 2011, 38(10):471-481
[5]	Kanai F, Marignani P A, Sarbassova D, et al.TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins[J].EMBO J, 2000, 19(24):6778-6791
[6]	左钱飞, 白艳涛, 李佳乐, 等.对发育和肿瘤的调控及其功能的研究进展[J].现代生物医学进展, 2013, 13(02):379-381
[7]	张丽娜, 占婷.信号通路与癌症相关研究进展[J].疑难病杂志, 2018, 17(12):1400-1404
[8]	Chen H I, Sudol M.The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules[J].Proc Natl Acad Sci U S A, 1995, 92(17):7819-7823
[9]	Strano S, Munarriz E, Rossi M, et al.Physical interaction with Yes-associated protein enhances p73 transcriptional activity[J].J Biol Chem, 2001, 276(18):15164-15173
[10]	Chan E H, Nousiainen M, Chalamalasetty R B, et al.The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1[J].Oncogene, 2005, 24(12):2076-2086
[11]	Harvey K, Tapon N.The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network[J].Nat Rev Cancer, 2007, 7(3):182-191
[12]	Zhao B, Li L, Lei Q, et al.The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version[J].Genes Dev, 2010, 24(9):862-874
[13]	Hoa L, Kulaberoglu Y, Gundogdu R, et al.The characterisation of LATS2 kinase regulation in Hippo-YAP signalling[J].Cell Signal, 2016, 28(5):488-497
[14]	Praskova M, Xia F, Avruch J.MOBKL1AMOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation[J].Curr Biol, 2008, 18(5):311-321
[15]	Sirio D, Leonardo M, Mariaceleste A, et al.Role of YAP/TAZ in mechanotransduction.[J].Nature, 2011, 474(7350):179-83
[16]	Aragona M, Panciera T, Manfrin A, et al.A mechanical checkpoint controls multicellular growth through YAPTAZ regulation by actin-processing factors[J].Cell, 2013, 154(5):1047-1059
[17]	Engler A J, Sen S, Sweeney H L, et al.Matrix elasticity directs stem cell lineage specification[J].Cell, 2006, 126(4):677-689
[18]	Pocaterra A, Santinon G, Romani P, et al.F-actin dynamics regulates mammalian organ growth and cell fate maintenance.[J].J Hepatol. 2019 Mar 14. pii: S0168-8278(19)30144-8., 2019, 8278(19):30144-8
[19]	Miller E, Yang J, DeRan M, et al.Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP[J].Chem Biol, 2012, 19(8):955-962
[20]	Cai H, Xu Y.The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells[J].Cell Commun Signal, 2013, 11(1):31-38
[21]	Mo J S, Yu F X, Gong R, et al.Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)[J].Genes Dev, 2012, 26(19):2138-2143
[22]	Koo J H, Guan K.Interplay between YAP/TAZ and Metabolism.[J].Cell Metab. 2018 Aug 7;28(2):196-206., 2018, 28(2):196-206
[23]	Mo J S, Meng Z, Kim Y C, et al.Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway[J].Nat Cell Biol, 2015, 17(4):500-510
[24]	Ma B, Chen Y, Chen L, et al.Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase[J].Nat Cell Biol, 2015, 17(1):95-103
[25]	Xiang L, Gilkes D M, Hu H, et al.Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype[J].Oncotarget, 2014, 5(24):12509-12527
[26]	Conley S J, Gheordunescu E, Kakarala P, et al.Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia[J].Proc Natl Acad Sci U S A, 2012, 109(8):2784-2789
[27]	Schwab L P, Peacock D L, Majumdar D, et al.Hypoxia-inducible factor 1alpha promotes primary tumor growth and tumor-initiating cell activity in breast cancer[J].Breast Cancer Res, 2012, 14(1):R6-87
[28]	Segrelles C, Paramio J M, Lorz C.The transcriptional co-activator YAP: A new player in head and neck cancer.[J].Oral Oncol, 2018, 8(6):25-32
[29]	苏冠月, 余泓池, 黄雯雯, 等.参与调控细胞上皮-间充质转化的研究进展[J].生物化学与生物物理进展, 2018, 45(07):705-713
[30]	Li L, Zhao J, Huang S, et al.MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.[J].Gene, 2018, 64(1):240-247
[31]	Wei K, Tingting H, Yuhang Z, et al.miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.[J].Cell Death Dis, 2018, 9(2):12-92
[32]	Youngeun K, Eek-Hoon J.Regulation of the Hippo signaling pathway by ubiquitin modification.[J].BMB Rep, 2018, 51(3):143-150
[33]	L S R, W W N, Takaaki S, et al.Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.[J].J Cell Biochem, 2018, 119(1):824-836
[34]	Chen X, Gu W, Wang Q, et al.C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC[J].Oncotarget, 2018, 9(1):668-679
[35]	Moya I M, Halder G.Hippo-YAPTAZ signalling in organ regeneration and regenerative medicine[J].Nat Rev Mol Cell Biol, 2019, 20(4):211-226
[36]	Zhou Z, Hao Y, Liu N, et al.TAZ is a novel oncogene in non-small cell lung cancer[J].Oncogene, 2011, 30(18):2181-2186
[37]	Chan S W, Lim C J, Guo K, et al.A role for TAZ in migration,invasion,and tumorigenesis of breast cancer cells[J].Cancer Res, 2008, 68(8):2592-2598
[38]	Hanahan D, Weinberg R A.Hallmarks of cancer: the next generation[J].Cell, 2011, 144(5):646-674
[39]	Zanconato F, Forcato M, Battilana G, et al.Genome-wide association between YAPTAZTEAD and AP-1 at enhancers drives oncogenic growth[J].Nat Cell Biol, 2015, 17(9):1218-1227
[40]	Skibinski A, Breindel J L, Prat A, et al.The Hippo transducer TAZ interacts with the SWISNF complex to regulate breast epithelial lineage commitment[J].Cell Rep, 2014, 6(6):1059-1072
[41]	Sharma S, Goswami R, Zhang D X, et al.TRPV4 regulates matrix stiffness and TGFβ1‐induced epithelial‐mesenchymal transition[J].J Cell Mol Med, 2019, 23(2):761-774
[42]	L C C, A W R.A perspective on cancer cell metastasis.[J].Science, 2011, 331(6024):1559-64
[43]	P S.The epithelial-mesenchymal transition (EMT) phenomenon.[J].Ann Oncol, 2010, 1(1):89-92
[44]	Zanconato F, Piccolo S.Eradicating tumor drug resistance at its YAP-biomechanical roots[J].EMBO J, 2016, 35(5):459-461
[45]	Liu-Chittenden Y, Huang B, Shim J S, et al.Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP[J].Genes Dev, 2012, 26(12):1300-1305
[46]	Kulkarni M, Tan T Z, Syed S N, et al.RUNX1 and RUNX3 protect against YAP-mediated EMT,stem-ness and shorter survival outcomes in breast cancer[J].Oncotarget, 2018, 9(18):14175-14192
[47]	Qiu B, Wei W, Zhu J, et al.EMT induced by loss of LKB1 promotes migration and invasion of liver cancer cells through ZEB1-induced YAP signaling[J].Oncol Lett, 2018, 16(5):6465-6471
[48]	van Rensburg Helena J J, Taha A, Min L, et al.The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.[J].Cancer Res, 2018, 78(6):1457-1470
[49]	Ni X, Tao J, Barbi J, et al.YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity[J].Cancer Discov, 2018, 8(8):1026-1043
[50]	Jiao S, Guan J, Chen M, et al.Targeting IRF3 as a YAP agonist therapy against gastric cancer[J].J Exp Med, 2018, 215(2):699-718
[51]	Beyer T A, Weiss A, Khomchuk Y, et al.Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells[J].Cell Rep, 2013, 5(6):1611-1624
[52]	Weiss A, Attisano L.The TGFbeta superfamily signaling pathway[J].Wiley Interdiscip Rev Dev Biol, 2013, 2(1):47-63
[53]	Varelas X, Sakuma R, Samavarchi-Tehrani P, et al.TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal[J].Nat Cell Biol, 2008, 10(7):837-848
[54]	Hiemer S E, Szymaniak A D, Varelas X.The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells[J].J Biol Chem, 2014, 289(19):13461-13474
[55]	Yadav S, Barton M J, Nguyen N.Biophysical properties of cells for cancer diagnosis.[J].J Biomech, 2019, 86(1):1-7
[56]	Natalie W L M, Yaqi D, Jincheng W, et al.Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.[J].Cancer Cell, 2018, 33(2):292-308
[57]	Lee H J, Ewere A, Diaz M F, et al.TAZ responds to fluid shear stress to regulate the cell cycle.[J].Cell Cycle, 2018, 17(2):147-153
[58]	Moreno-Vicente R, Pavón D M, Martín-Padura I, et al.Caveolin-1 Modulates Mechanotransduction Responses to Substrate Stiffness through Actin-Dependent Control of YAP[J].Cell Rep, 2018, 25(6):1622-1635
[59]	Junling L, Liping Y, Qingyuan L, et al.Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.[J].J Pathol, 2018, 244(1):71-83
[60]	Kai Y, Shengchun D, Lei C, et al.Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity.[J].Biochem Biophys Res Commun, 2018, 496(1):76-82
[61]	Zhen S, Anja S, Tristan R, et al.Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition.[J].Cancer Res. 2018 Feb 15;78(4):950-961., 2018, 78(4):950-961
[62]	Zhang X, Zhao H, Li Y, et al.The role of YAPTAZ activity in cancer metabolic reprogramming[J].Mol Cancer, 2018, 17(1):134-144
[63]	Oliver-De L C J, Nardone G, Vrbsky J, et al.Substrate mechanics controls adipogenesis through YAP phosphorylation by dictating cell spreading.[J].Biomaterials, 2019, 205(1):64-80
[64]	Parrales A, Thoenen E, Iwakuma T.The interplay between mutant p53 and the mevalonate pathway[J].Cell Death Differ, 2018, 25(3):460-470
[65]	Di Agostino S, Valenti F, Sacconi A, et al.Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma[J].Theranostics, 2018, 8(7):1850-1868
[66]	Ehsanian R, Brown M, Lu H, et al.YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation,survival and migration in head and neck cancer subsets[J].Oncogene, 2010, 29(46):6160-6171
[67]	Saladi S V, Ross K, Karaayvaz M, et al.ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation,Regenerative Proliferation,and Poor Prognosis[J].Cancer Cell, 2017, 31(1):35-49
[68]	Verduci L, Ferraiuolo M, Sacconi A, et al.The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53YAPTEAD transcription-competent complex[J].Genome Biol, 2017, 18(1):237-246
[69]	周雅青, 杨蓉, 马刚.沉默可抑制鼻咽癌细胞的增殖、迁移及侵袭能力[J].南方医科大学学报, 2019, 39(03):286-291
[70]	Wei Z, Wang Y, Li Z, et al.Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis[J].J Oral Pathol Med, 2013, 42(10):747-754
[71]	Li Z, Wang Y, Zhu Y, et al.The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer[J].Mol Oncol, 2015, 9(6):1091-1105
[72]	Hiemer S E, Zhang L, Kartha V K, et al.A YAPTAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma[J].Mol Cancer Res, 2015, 13(6):957-968
[73]	涂敏松, 李逸松, 张雄.蛋白在口腔鳞状细胞癌中的表达及意义[J].上海口腔医学, 2018, 27(04):415-418